obesity

Orexigen's Contrave Has Modest Start
Seeking Alpha
Mon, 11/3/14 - 06:42 pm
Orexigen
Contrave
obesity
3 Pharma Companies Fighting Obesity
Yahoo/Benzinga
Thu, 10/30/14 - 05:33 pm
obesity
Orexigen
Arena
Vivus
Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets
Yahoo
Mon, 10/20/14 - 09:10 am
Takeda
Orexigen
Contrave
obesity
Novo Nordisk Establishes New Obesity Research Unit
Drug Discovery and Development
Mon, 09/29/14 - 06:40 pm
Novo Nordisk
obesity
R&D
Are obesity drugs nearing a breakout? Novo, Takeda think so
Fierce Pharma
Thu, 09/18/14 - 09:18 am
Novo Nordisk
Takeda
obesity
Saxenda
Armed with 900 reps, Takeda aims for the Contrave marketing hat-trick
Fierce Pharma Marketing
Wed, 09/17/14 - 05:10 pm
Takeda
drug reps
Contrave
obesity
Orexigen
Novo May Add Hundreds to R&D Staff for Obesity Medicines
Bloomberg
Wed, 09/17/14 - 08:38 am
Novo Nordisk
R&D
hirings
Saxenda
obesity
Doc Offers Glimpse Into Arena Pharma Weight-Loss Combination Therapy
TheStreet.com
Tue, 09/16/14 - 10:18 am
Arena Pharmaceuticals
Belviq
obesity
phentermine
Arena Down On The Back Of Weight-Loss Drug Failure
Bidness Etc.
Mon, 09/15/14 - 07:28 pm
Arena Pharmaceuticals
obesity
Belviq
Selling Obesity Drugs to Americans Shouldn't Be This Hard
Bloomberg/Businessweek
Mon, 09/15/14 - 09:18 am
obesity
Orexigen
Contrave
Qsymia
Belviq
Arena Pharmaceuticals
Eisai
Safety warnings will hold back new obesity treatment Contrave
Pharmaphorum
Fri, 09/12/14 - 08:41 am
Orexigen
Takeda
obesity
Contrave
Orexigen's Obesity Pill is Approved and Stock Falls. Don't be Surprised
TheStreet.com
Thu, 09/11/14 - 05:21 pm
Orexigen
Contrave
FDA
obesity
Novo’s Weight-Loss Shot Wins Backing of U.S. Advisers
Bloomberg
Thu, 09/11/14 - 04:44 pm
Novo Nordisk
FDA
obesity
vaccines
Saxenda
liraglutide
FDA Approves Contrave Weight Loss Drug From Orexigen And Takeda
Forbes
Wed, 09/10/14 - 08:37 pm
FDA
Contrave
obesity
Orexigen
Takeda
FDA staff: Novo Nordisk drug liraglutide effective for obesity
Yahoo/Reuters
Tue, 09/9/14 - 10:03 am
FDA
Novo Nordisk
liraglutide
obesity
Victoza
More Obesity Drugs Seek to Enter Still Struggling Market
Bloomberg
Tue, 09/9/14 - 08:08 am
obesity
Orexigen
Novo Nordisk
NB32
liraglutide
Victoza
Takeda
You’ve got obesity all wrong: Zafgen CEO
CNBC
Tue, 08/19/14 - 01:44 pm
obesity
Zafgen
Pharma CEOs
beloranib
Arena Sees Belviq Sales Climb Despite Seasonality
Seeking Alpha
Fri, 07/25/14 - 05:55 pm
Belviq
obesity
Arena Pharmaceuticals
The Implications of Obesity as a Disability in Europe
Motley Fool
Sun, 07/20/14 - 09:10 am
obesity
weight loss
Arena Pharmaceuticals
Belviq
Orexigen
Vivus
Eisai
Qsymia
NB32
Zafgen Supersizes Its Obesity-Focused IPO: An Early Investor's Reflections
Forbes
Wed, 06/25/14 - 07:44 am
Zafgen
obesity
IPOs

Pages